Annex

United Kingdom

The entry monepantel in Table 1 of the Annex to Regulation (EU) No 37/2010 is replaced by the following:

Pharmacologically active Substance Marker residue Animal Species MRL Target Tissues Other Provisions(according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic Classification
‘Monepantel Monepantel-sulfone Ovine, caprine 700 μg/kg Muscle Not for use in animals producing milk for human consumption. Antiparasitic agents/Agents acting against endoparasites’
7 000 μg/kg Fat
5 000 μg/kg Liver
2 000 μg/kg Kidney

Pharmacologically active Substance	Marker residue	Animal Species	MRL	Target Tissues	Other Provisions(according to Article 14(7) of Regulation (EC) No 470/2009)	Therapeutic Classification
‘Monepantel	Monepantel-sulfone	Ovine, caprine	700 μg/kg	Muscle	Not for use in animals producing milk for human consumption.	Antiparasitic agents/Agents acting against endoparasites’
			7 000 μg/kg	Fat
			5 000 μg/kg	Liver
			2 000 μg/kg	Kidney